Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis

Hepatology

Volumn 34, Issue 3, 2001, Pages 487-493

  Cejudo Martín, Pilar ^a   Ros, Josefa ^a   Navasa, Miguel ^a   Fernández, Javier ^a   Fernádez Varo, Guillermo ^a   Ruiz del Arbol, Luis ^b   Rivera, Francisca ^a   Arroyo, Vicente ^a   Rodés, Juan ^a   Jiménez, Wladimiro ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BACTERIAL PERITONITIS; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034872638     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.27093     Document Type: Article

References (33)

1. Infections in liver disease
2. Spontaneous bacterial peritonitis
3. Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime
4. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality
5. Vascular endothelial growth factor and microvascular permeability
6. Tumors cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
7. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: Regulation by cytokines and bacterial lipopolysaccharide
8. A simple method for the purification of human peripheral blood monocytes. A substitute for sepracell-MN
9. Effect of bacterial lipopolysaccharide on Endothelin-1 production in human vascular endothelial cells
10. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets
11. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
12. Increased DNA methyltransferase expression in rhabdomyosarcomas
13. Molecular structure of the human cytoplasmatic β-actin gene: Interspecies homology of sequences in the introns
14. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation
15. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
16. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor
17. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries
18. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma
19. Interactions between human monocytes and vascular smooth muscle cells induces vascular endothelial growth factor expression
20. Vascular endothelial growth factor (VEGF)
21. Milky spots in the mouse omentum may play an important role in the origin of peritoneal macrophages
22. Cellular composition of milky spots in the human greater omentum: An immunochemical and ultrastructural study
23. Human neutrophils secrete vascular endothelial growth factor
24. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis
25. The biology of vascular endothelial growth factor
26. Target effector role of vascular endothelium in the inflammatory response: Insights from the clinical trial of anti-TNFα antibody in rheumatoid arthritis
27. Antisense oligonucleotides inhibit vascular endothelial growth factor/vascular permeability factor expression in normal human epidermal keratinocytes
28. Vascular endothelial growth factor and its receptors
29. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
30. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
31. Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells
32. Activation of Mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of Prolactin
33. VEGF121 a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells